Cannabis Use Is Soaring Among Older Adults—and Clinicians Are Largely Unprepared
Cannabis use older adults risks are rising as usage grows tenfold in two decades. This 2025 evidence review highlights pharmacokinetic changes and drug interactions unique to seniors. Clinicians face challenges guiding cannabis use with limited…
CBD Gummies What They Do: A Practical Look at Effects, Evidence, and Everyday Use
CBD gummies pharmacokinetics are essential to understand their absorption and onset timing. These factors influence the therapeutic effects and dosing recommendations. This knowledge helps patients and clinicians manage expectations for everyday use.
What Are Your Questions About Women and Cannabis? – CNN
Women cannabis pharmacokinetics reveal important sex-based differences in metabolism and efficacy. Hormonal fluctuations significantly influence how women process cannabinoids. Understanding these differences is crucial for personalized clinical cannabis…
Understanding THC Beverages: Clinical Insights and Pharmacokinetics
THC beverages pharmacokinetics clinical insights reveal faster onset and unique dosing considerations compared to traditional edibles. Understanding these factors is crucial for patient safety and effective clinical guidance. This knowledge helps…
A marijuana breathalyzer is one step closer to coming to market | The Independent
The breath-based detection method cannabis technology is advancing towards real-time impairment assessment. Current cannabis impairment detection relies on less accurate blood or urine tests. This new method could improve clinical and law enforcement…
Why Cannabis Impairment Testing Remains a Clinical Challenge
Cannabis impairment testing challenges complicate legal and clinical assessments of driving safety. THC blood levels do not reliably indicate actual impairment due to complex pharmacokinetics. Patients using medicinal cannabis face risks of legal…
India to Start Human Trials for Medicinal Cannabis
India medicinal cannabis trials mark a pivotal shift in drug policy and research. These human trials aim to produce controlled safety and efficacy data. This research could accelerate medicinal cannabis acceptance across South and Southeast Asia.